[Options in palliative therapy for penile cancer].
Penile cancer, with an incidence of 0.1-0.9/100,000 males/year, is one of the least common malignant tumors. Most patients are over 50 years old and the tumor is slow growing. Therapeutic success is highly dependent on lymph node status. Cancer related death is usually due to local complications such as arrosion bleeding caused by the tumor or infected inguinal metastases. The therapy for advanced penile cancer and its complications represents a challenge. Taking into consideration quality of life, the therapeutic strategy should be based on the patient's age, his sexual function, motivation and psychological condition, as well as previous illnesses and tumor biology. Palliative therapy requires good interdisciplinary work between oncologists, radiologists, plastic surgeons, physiotherapists and psychologists.
Preis
E
E
Urologische Klinik, Universitätsklinikum der RWTH, 52072, Pauwelsstrasse 30, Aachen, Deutschland. epreis@ukaachen.de
Jakse
G
G
D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D010166:Palliative Care / Q000379:methods*; D010412:Penile Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D013727:Terminal Care / Q000379:methods*